Imagine a shape-shifting pathogen invisible to the naked eye, armed with toxin-laced barbs that rupture human cells. This isn’t fiction—it’s Clostridioides difficile, a superbug causing 29,000 U.S. deaths annually through severe diarrhea and colitis. After an initial infection, up to 35% of patients experience recurrence, with subsequent episodes becoming increasingly likely—up to 60% of these…
The role of the democratized research network in optimizing precision dosing
Historically, healthcare organizations have followed the lead of published research on the efficacy of pharmacokinetic (PK) models to support point-of-care precision dosing. When a respected journal publishes a robust, peer-validated PK model analysis, clinicians often heed the results and accept that model as their organization’s default for the drug in question. However, new research shows…